Novanta Inc. (NOVT)

Market Cap	4.16B
Revenue (ttm)	956.88M
Net Income (ttm)	61.36M
Shares Out	35.97M
EPS (ttm)	1.69
PE Ratio	68.44
Forward PE	32.88
Dividend	n/a
Ex-Dividend Date	n/a

Volume	425,361
Open	114.15
Previous Close	113.73
Day's Range	113.55 - 116.04
52-Week Range	98.76 - 186.75
Beta	1.48
Analysts	Hold
Price Target	160.00 (+38.33%)
Earnings Date	Aug 5, 2025

About AUGX

Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. It operates in two segments, Automation Enabling Technologies and Medical Solutions. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam delivery components, laser beam delivery solutions, CO2 lasers, solid state lasers, ultrafast lasers, optical and inductive encoders, precision...

• Industry: Scientific & Technical Instruments
• Sector: Technology
• Founded: 1968
• Employees: 3,000
• Stock Exchange: NASDAQ
• Ticker Symbol: NOVT
• Website: https://www.novanta.com

Financial Performance

In 2024, Novanta's revenue was $949.25 million, an increase of 7.67% compared to the previous year's $881.66 million. Earnings were $64.09 million, a decrease of -12.06%.

Analyst Summary

According to one analyst, the rating for NOVT stock is "Hold" and the 12-month stock price target is $160.0.

Price Target

$160.0

(38.33% upside)

Analyst Consensus: Hold